| Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism. | |
| | |
MedLine Citation:
|
PMID: 11401194 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The pharmacodynamic properties of low-molecular-weight heparins differ. Data from randomized clinical trials show that despite these differences, the agents have similar efficacy and safety profiles in preventing and treating new and recurrent venous thromboembolism in patients who underwent general surgery or total hip or knee replacement. Dalteparin, enoxaparin, or tinzaparin, when administered at the dosages used in the reviewed clinical trials, are essentially indistinguishable. |
| | |
Authors:
|
L M Lopez |
Related Documents
:
|
9549534 - Dalteparin for deep venous thrombosis: a hospital-in-the-home program. 20431444 - Nurse-driven intravenous heparin protocol: quality improvement initiative. 6993494 - Can the results of treatment of deep venous thrombosis be improved by combining surgica... 11210954 - Graduated compression stockings: knee length or thigh length. 17000454 - Surgical outcome of aortopulmonary window repair in early infancy. 7097964 - Replicable abstinence rates in an alcoholism treatment program. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Pharmacotherapy Volume: 21 ISSN: 0277-0008 ISO Abbreviation: Pharmacotherapy Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-06-12 Completed Date: 2001-12-07 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8111305 Medline TA: Pharmacotherapy Country: United States |
Other Details:
|
Languages: eng Pagination: 56S-61S; discussion 71S-72S Citation Subset: IM |
Affiliation:
|
College of Pharmacy, University of Florida, Gainesville 32610-0486, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Clinical Trials as Topic Dalteparin / administration & dosage, adverse effects, therapeutic use* Enoxaparin / administration & dosage, adverse effects, therapeutic use* Heparin, Low-Molecular-Weight / administration & dosage, adverse effects, therapeutic use* Humans Pulmonary Embolism / drug therapy, prevention & control Venous Thrombosis / drug therapy*, prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Dalteparin; 0/Enoxaparin; 0/Heparin, Low-Molecular-Weight; 0/tinzaparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New developments in the prevention and treatment of venous thromboembolism.
Next Document: Differentiation of the low-molecular-weight heparins.